Neuroloxía
Servicio
Hospital General Universitario de Alicante
Alicante, EspañaPublicacións en colaboración con investigadores/as de Hospital General Universitario de Alicante (16)
2024
-
Palliative care management in patients with Parkinson's disease and other movement disorders. National survey to neurologists
Neurologia, Vol. 39, Núm. 5, pp. 417-425
2023
-
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193
2022
-
Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder
Journal of Personalized Medicine, Vol. 12, Núm. 5
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
-
Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients’ Perspective: An Observational Cross-Sectional Study
Neurology and Therapy, Vol. 11, Núm. 3, pp. 1101-1116
2021
-
Alzemon: estudio de seguimiento prospectivo del acetato de eslicarbacepina en monoterapia en pacientes con epilepsia de diagnóstico reciente
Revista de neurologia, Vol. 72, Núm. 8, pp. 263-268
-
Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID national registry
Journal of Clinical Medicine, Vol. 10, Núm. 19
-
MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention
Journal of Headache and Pain, Vol. 22, Núm. 1
-
Quantifying the patient's perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire
PLoS ONE, Vol. 16, Núm. 7 July
-
Spanish expert consensus on the use of safinamide in Parkinson's disease
Neurologia, Vol. 36, Núm. 9, pp. 666-672
2020
-
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Frontiers in Neurology, Vol. 11
2018
-
OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study
European Journal of Neurology, Vol. 25, Núm. 2, pp. 411-416
2017
-
Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: A prospective observational study
Journal of Translational Medicine, Vol. 15, Núm. 1
-
Distribution and genotype-phenotype correlation of GDAP1 mutations in Spain
Scientific Reports, Vol. 7, Núm. 1
2016
-
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression
BMC Neurology, Vol. 16, Núm. 1
-
NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy
Epilepsy and Behavior, Vol. 65, pp. 25-32